Agios Pharmaceuticals | Satış Ve Yönetim Giderleri



Selling And Administration Expenses Değişiklik Tarih
AbbVie USD 3.29B 562M 2025-03
Agios Pharmaceuticals USD 41.53M 10.17M 2025-03
Alnylam Pharmaceuticals USD 239.95M 55.39M 2025-03
Amgen USD 1.69B 191M 2025-03
Arrowhead Research USD 30.2M 1.91M 2024-12
Astellas Pharma JPY 211.32B 13.99B 2025-03
AstraZeneca USD 3.59B 1.96B 2025-03
Bayer EUR 4.34B 610M 2024-12
Biogen USD 572.5M 104.8M 2025-03
BioMarin Pharmaceutical USD 206.12M 50.65M 2025-03
Bristol-Myers Squibb USD 1.58B 521M 2025-03
Daiichi Sankyo JPY 208.21B 22.58B 2025-03
Eli Lilly USD 2.36B 62.3M 2025-03
Exelixis USD 134.33M 22.53M 2025-01
Gilead Sciences USD 1.26B 603M 2025-03
GlaxoSmithKline GBP 2.06B 603M 2025-03
Incyte USD 325.69M 1.02M 2025-03
Ionis Pharmaceuticals USD 76M 12.08M 2025-03
Merck USD 2.53B 319M 2025-03
Moderna USD 212M 139M 2025-03
Novartis USD 3.5B 368M 2024-12
Novartis USD 3.5B 368M 2024-12
Pfizer USD 3.01B 1.27B 2025-03
Regeneron Pharmaceuticals USD 633M 159.2M 2025-03
Roche Holding CHF 3.61B 381M 2024-12
Sarepta Therapeutics USD 163.87M 35.67M 2024-12
Vertex Pharmaceuticals USD 377.6M 5.8M 2024-12



Agios Pharmaceuticals Satış Ve Yönetim Giderleri - Akım değerleri, tarihsel veriler, tahminler, istatistikler, grafikler ve ekonomik takvim - May 2025.